GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4954)

  • GC91176 structure
    GC91176AOH1996
    CAS: 2089314-64-5
    Purity: >99.00%

    PCNAの阻害剤

  • GC91181 structure
    GC91181Malathion-d10
    CAS: 347841-48-9
    Purity: >99.00%

    マラチオンの定量化のための内部標準

  • GC91220 structure
    GC91220Polymyxin E1 (sulfate)
    CAS: 207990-63-4
    Purity: >90.00%

    ペプチド抗生物質であり、コリスチンの主要成分です。

  • GC91221 structure
    GC91221Polymyxin B2 (sulfate)
    CAS: 108965-69-1
    Purity: >90.00%

    抗生物質であり、ポリミキシンBの主要成分

  • GC91228 structure
    GC91228SSE1806
    Purity: >95.00%

    マイクロチューブの不安定化剤

  • GC91229 structure
    GC91229DXR Inhibitor 11a (free acid)
    CAS: 2260608-07-7
    Purity: >98.00%

    「P. falciparum」のDXR阻害剤

  • GC91241 structure
    GC912419-keto Tafluprost
    CAS: 261179-75-3
    Purity: >95.00%

    タフルプロストの誘導体

  • GC91294 structure
    GC91294S-Geranylgeranyl-L-glutathione
    CAS: 2364639-42-7
    Purity: >98.00%

    P2RY8のリガンド

  • GC91295 structure
    GC91295PPZ-A10
    CAS: 2941268-67-1
    Purity: >98.00%

    イオン化可能な陽イオン性脂質

  • GC91296 structure
    GC91296p-Carboxyphenyl Sulfate
    CAS: 3233-38-3
    Purity: >95.00%

    硫酸化されたフェノール酸

  • GC91297 structure
    GC91297Cholesterol-Doxorubicin
    Purity: >95.00%

    ドキソルビシンのプロドラッグ形態

  • GC91298 structure
    GC91298(±)-Linalool-d3
    CAS: 1216673-02-7
    Purity: >99.00%

    (±)-リナロールの定量化のための内部標準

  • GC91355 structure
    GC91355Chlorphenesin Carbamate
    CAS: 886-74-8
    Purity: >98.00%

    クロルフェネシンカルバメートは筋肉弛緩剤です。

  • GC91359 structure
    GC91359(R)-(4-Bromophenyl)(phenyl)methanamine
    CAS: 220441-81-6
    Purity: >95.00%

    (R)-(4-ブロモフェニル)(フェニル)メタンアミンは合成中間体です。

  • GC91360 structure
    GC91360NM-3
    CAS: 181427-78-1
    Purity: >98.00%

    NM-3は合成イソクマリンであり、血管新生の阻害剤です。

  • GC91375 structure
    GC91375Promethazine Sulfoxide
    CAS: 7640-51-9
    Purity: >95.00%

    プロメタジンスルホキシドは、ヒスタミンH1受容体拮抗剤であるプロメタジンの代謝物です。

  • GC91379 structure
    GC91379BDW568
    CAS: 335401-44-0
    Purity: >98.00%

    BDW568は、干渉素遺伝子刺激因子(STING)のアゴニストであり、BDW-OHのプロドラッグ形態です。

  • GC91380 structure
    GC91380N6F11
    CAS: 851398-76-0
    Purity: >99.50%

    N6F11はフェロプトーシスの誘導剤です。

  • GC91389 structure
    GC91389J27644
    Purity: >95.00%

    J27644は、ヒストンデアセチラーゼ6(HDAC6; IC50 = 10 nM)の阻害剤です。

  • GC91397 structure
    GC91397N-desmethyl Levofloxacin (hydrochloride)
    Purity: >98.00%

    N-デスメチルレボフロキサシンは、フルオロキノロン系抗生物質であるレボフロキサシンの有効代謝産物です。

  • GC91406 structure
    GC91406UK 122 (trifluoroacetate salt)
    CAS: 1186653-73-5
    Purity: >95.00%

    UK 122は、尿濾過型プラスミノーゲン活性化因子(uPA; IC50 = 0.2 µM)の阻害剤です。

  • GC91424 structure
    GC91424S1PL-IN-31
    CAS: 1538574-95-6
    Purity: >98.00%

    S1PL-IN-31は、スフィンゴシン-1-リン酸(S1P)ライアーゼの阻害剤であり(IC50 = 210 nM)、です。

  • GC91449 structure
    GC91449Ipamorelin (acetate)
    Purity: >98.00%

    イパモレリンは、ペンタペプチド成長ホルモン分泌促進剤(GHS)およびGHS受容体1a(GHS-R1a)アゴニストです。

  • GC91590 structure
    GC91590DTPD-Q
    CAS: 252950-56-4
    Purity: >98.00%

    DTPD-Q is an oxidized derivative of the antioxidant and methylphenyl substituted p-phenylenediamine DTPD.